AAAAAA
Results: 1-25/35
Authors:
Barry, MJ
Roehrborn, CG
Citation: Mj. Barry et Cg. Roehrborn, Extracts from "Clinical Evidence" - Benign prostatic hyperplasia, BR MED J, 323(7320), 2001, pp. 1042-1046
Authors:
Anderson, JB
Roehrborn, CG
Schalken, JA
Emberton, M
Citation: Jb. Anderson et al., The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk, EUR UROL, 39(4), 2001, pp. 390-398
Authors:
Roehrborn, CG
Bartsch, G
Kirby, R
Andriole, G
Boyle, P
De La Rosette, J
Perrin, P
Ramsey, E
Nordling, J
Freire, GD
Arap, S
Citation: Cg. Roehrborn et al., Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: A comparative, international overview, UROLOGY, 58(5), 2001, pp. 642-650
Authors:
Boyle, P
Robertson, C
Manski, R
Padley, RJ
Roehrborn, CG
Citation: P. Boyle et al., Meta-analysis of randomized trials of terazosin in the treatment of benignprostatic hyperplasia, UROLOGY, 58(5), 2001, pp. 717-722
Authors:
Baldwin, KC
Ginsberg, PC
Roehrborn, CG
Harkaway, RC
Citation: Kc. Baldwin et al., Discontinuation of alpha-blockade after initial treatment with finasterideand doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia, UROLOGY, 58(2), 2001, pp. 203-208
Authors:
Roehrborn, CG
Malice, MP
Cook, TJ
Girman, CJ
Citation: Cg. Roehrborn et al., Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: A comprehensive analysis of the pooled placebo groups of several large clinical trials, UROLOGY, 58(2), 2001, pp. 210-216
Authors:
Showalter, PR
Zimmern, PE
Roehrborn, CG
Lemack, GE
Citation: Pr. Showalter et al., Standing cystourethrogram: An outcome measure after anti-incontinence procedures and cystocele repair in women, UROLOGY, 58(1), 2001, pp. 33-37
Authors:
Roehrborn, CG
Sech, S
Montoya, J
Rhodes, T
Girman, CJ
Citation: Cg. Roehrborn et al., Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination, UROLOGY, 57(6), 2001, pp. 1087-1092
Authors:
McNeill, SA
Hargreave, TB
Geffriaud-Ricouard, C
Santoni, JP
Roehrborn, CG
Citation: Sa. Mcneill et al., Postvoid residual urine in patients with lower urinary tract symptoms succestive of benign prostatic hyperplasia: Pooled analysis of eleven controlled studies with alfuzosin, UROLOGY, 57(3), 2001, pp. 459-465
Authors:
Djavan, B
Seitz, C
Roehrborn, CG
Remzi, M
Fakhari, M
Waldert, M
Basharkhah, A
Planz, B
Harik, M
Marberger, M
Citation: B. Djavan et al., Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: Outcomes at 18 months, UROLOGY, 57(1), 2001, pp. 66-70
The impact of intense laparoscopic skills training on the operative performance of urology residents
Authors:
Traxer, O
Gettman, MT
Napper, CA
Scott, DJ
Jones, DB
Roehrborn, CG
Pearle, MS
Cadeddu, JA
Citation: O. Traxer et al., The impact of intense laparoscopic skills training on the operative performance of urology residents, J UROL, 166(5), 2001, pp. 1658-1661
Authors:
Sech, S
Montoya, J
Girman, CJ
Rhodes, T
Roehrborn, CG
Citation: S. Sech et al., Interexaminer reliability of transrectal ultrasound for estimating prostate volume, J UROL, 166(1), 2001, pp. 125-129
Authors:
Roehrborn, CG
Bruskewitz, R
Nickel, GC
Glickman, S
Cox, C
Anderson, R
Kandzari, S
Herlihy, R
Kornitzer, G
Brown, BT
Holtgrewe, HL
Taylor, A
Wang, D
Waldstreicher, J
Citation: Cg. Roehrborn et al., Urinary retention in patients with BPH treated with finasteride or placeboover 4 years - Characterization of patients and ultimate outcomes, EUR UROL, 37(5), 2000, pp. 528-536
Authors:
Roehrborn, CG
Citation: Cg. Roehrborn, Advances in the management of benign prostatic hyperplasia - Introduction, UROLOGY, 56(5A), 2000, pp. 1-2
Authors:
Roehrborn, CG
Citation: Cg. Roehrborn, Acute relief or future prevention: Is urology ready for preventive health care?, UROLOGY, 56(5A), 2000, pp. 12-19
Authors:
Lemack, GE
Dewey, RB
Roehrborn, CG
O'Suilleabhain, PE
Zimmern, PE
Citation: Ge. Lemack et al., Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease, UROLOGY, 56(2), 2000, pp. 250-254
Authors:
Roehrborn, CG
Dolte, KS
Ross, KS
Girman, CJ
Citation: Cg. Roehrborn et al., Incidence and risk reduction of long-term outcomes: A comparison of benignprostatic hyperplasia with several other disease areas, UROLOGY, 56(1), 2000, pp. 9-18
Authors:
Roehrborn, CG
Citation: Cg. Roehrborn, Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate - Editorial comment, UROLOGY, 55(5), 2000, pp. 687-688
Authors:
Yanoshak, SJ
Roehrborn, CG
Girman, CJ
Jaffe, JS
Ginsberg, PC
Harkaway, RC
Citation: Sj. Yanoshak et al., Use of a prostate model to assist in training for digital rectal examination, UROLOGY, 55(5), 2000, pp. 690-693
Authors:
Djavan, B
Partin, AW
Hoey, MF
Roehrborn, CG
Dixon, CM
Marberger, M
Citation: B. Djavan et al., Transurethral radiofrequency therapy for benign prostatic hyperplasia using a novel saline-liquid conductor: The virtual electrode, UROLOGY, 55(1), 2000, pp. 13-16
Authors:
Gajewski, JB
Chancellor, MB
Ackman, CFD
Appell, RA
Bennett, J
Binard, J
Boone, TB
Chetner, MP
Crewalk, JA
Defalco, A
Foote, J
Green, B
Juma, S
Jung, SY
Linsenmeyer, TA
Macaluso, JN
Macmillan, R
Mayo, M
Ozawa, H
Roehrborn, CG
Schmidt, J
Shenot, PJ
Stone, A
Vazquez, A
Killorin, W
Rivas, DA
Citation: Jb. Gajewski et al., Removal of UroLume endoprosthesis: Experience of the North American study group for detrusor-sphincter dyssynergia application, J UROL, 163(3), 2000, pp. 773-776
Authors:
Roehrborn, CG
McConnell, J
Bonilla, J
Rosenblatt, S
Hudson, PB
Malek, GH
Schellhammer, PF
Bruskewitz, R
Matsumoto, AM
Harrison, LH
Fuselier, HA
Walsh, P
Roy, J
Andriole, G
Resnick, M
Waldstreicher, J
Citation: Cg. Roehrborn et al., Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia, J UROL, 163(1), 2000, pp. 13-20
Authors:
Pearle, MS
Roehrborn, CG
Pak, CYC
Citation: Ms. Pearle et al., Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis, J ENDOUROL, 13(9), 1999, pp. 679-685
Authors:
Albertsen, PC
Pellissier, JM
Lowe, FC
Girman, CJ
Roehrborn, CG
Citation: Pc. Albertsen et al., Economic analysis of finasteride: A model-based approach using data from the Proscar (R) long-term efficacy and safety study, CLIN THER, 21(6), 1999, pp. 1006-1024
Authors:
Roehrborn, CG
Boyle, P
Bergner, D
Gray, T
Gittelman, M
Shown, T
Melman, A
Bracken, RB
White, RD
Taylor, A
Wang, D
Waldstreicher, J
Citation: Cg. Roehrborn et al., Serum prostate-specific antigen and prostate volume predict long-term chances in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo, UROLOGY, 54(4), 1999, pp. 662-669